219 related articles for article (PubMed ID: 38256245)
1. Programmed Death-Ligand (PD-L1), Epidermal Growth Factor (EGF), Relaxin, and Matrix Metalloproteinase-3 (MMP3): Potential Biomarkers of Malignancy in Canine Mammary Neoplasia.
Galadima M; Teles M; Pastor J; Hernández-Losa J; Rodríguez-Gil JE; Rivera Del Alamo MM
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256245
[TBL] [Abstract][Full Text] [Related]
2. PD-L1 mRNA and protein expression in canine mammary carcinomas: Correlation with histopathological grade and molecular markers.
Bae MK; Ko YU; Seung BJ; Sur JH; Choe NH
Vet Pathol; 2024 May; 61(3):402-409. PubMed ID: 38281145
[TBL] [Abstract][Full Text] [Related]
3. Increased programmed death ligand (PD-L1) and cytotoxic T-lymphocyte antigen-4 (CTLA-4) expression is associated with metastasis and poor prognosis in malignant canine mammary gland tumours.
Ariyarathna H; Thomson NA; Aberdein D; Perrott MR; Munday JS
Vet Immunol Immunopathol; 2020 Dec; 230():110142. PubMed ID: 33129194
[TBL] [Abstract][Full Text] [Related]
4. Hormone Receptor Expression Analyses in Neoplastic and Non-Neoplastic Canine Mammary Tissue by a Bead Based Multiplex Branched DNA Assay: A Gene Expression Study in Fresh Frozen and Formalin-Fixed, Paraffin-Embedded Samples.
Mohr A; Lüder Ripoli F; Hammer SC; Willenbrock S; Hewicker-Trautwein M; Kiełbowicz Z; Murua Escobar H; Nolte I
PLoS One; 2016; 11(9):e0163311. PubMed ID: 27649560
[TBL] [Abstract][Full Text] [Related]
5. The metastatic potential of canine mammary tumours can be assessed by mRNA expression analysis of connective tissue modulators.
Lamp O; Honscha KU; Schweizer S; Heckmann A; Blaschzik S; Einspanier A
Vet Comp Oncol; 2013 Mar; 11(1):70-85. PubMed ID: 22235833
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the local expression of the relaxin system in canine mammary tumours.
Lamp O; Honscha KU; Jakob J; Lamp J; Schweizer S; Reischauer A; Gottschalk J; Hahn A; Ebert M; Rothemund S; Blaschzik S; Einspanier A
Reprod Domest Anim; 2009 Jul; 44 Suppl 2():224-9. PubMed ID: 19754574
[TBL] [Abstract][Full Text] [Related]
7. Five markers useful for the distinction of canine mammary malignancy.
Pawłowski KM; Maciejewski H; Majchrzak K; Dolka I; Mol JA; Motyl T; Król M
BMC Vet Res; 2013 Jul; 9():138. PubMed ID: 23844591
[TBL] [Abstract][Full Text] [Related]
8. Characterization of expression and prognostic implications of transforming growth factor beta, programmed death-ligand 1, and T regulatory cells in canine histiocytic sarcoma.
Murphy JD; Shiomitsu K; Milner RJ; Lejeune A; Ossiboff RJ; Gell JC; Axiak-Bechtel S
Vet Immunol Immunopathol; 2023 Mar; 257():110560. PubMed ID: 36804838
[TBL] [Abstract][Full Text] [Related]
9. Canine Mammary Neoplasia Induces Variations in the Peripheral Blood Levels of CD20, CD45RA, and CD99.
Galadima M; Kotova I; Schmidt R; Pastor J; Schröder C; Rodríguez-Gil JE; Del Alamo MMR
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298173
[TBL] [Abstract][Full Text] [Related]
10. Relationship between receptors for epidermal growth factor and steroid hormones in normal, dysplastic and neoplastic canine mammary tissues.
Donnay I; Devleeschouwer N; Wouters-Ballman P; Leclercq G; Verstegen J
Res Vet Sci; 1996 May; 60(3):251-4. PubMed ID: 8735517
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Gene Expression Signatures in Cancer-Associated Stroma from Canine Mammary Tumours Reveals Molecular Homology to Human Breast Carcinomas.
Ettlin J; Clementi E; Amini P; Malbon A; Markkanen E
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28531107
[TBL] [Abstract][Full Text] [Related]
12. Progesterone receptor isoform analysis by quantitative real-time polymerase chain reaction in formalin-fixed, paraffin-embedded canine mammary dysplasias and tumors.
Guil-Luna S; Stenvang J; Brünner N; Sánchez-Céspedes R; Millán Y; Gómez-Laguna J; de las Mulas JM
Vet Pathol; 2014 Sep; 51(5):895-902. PubMed ID: 24249219
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of vascular endothelial growth factor and hypoxia-inducible factor 1α in canine malignant mammary tumors.
Moschetta MG; Maschio LB; Jardim-Perassi BV; Gelaleti GB; Lopes JR; Leonel C; Gonçalves Ndo N; Ferreira LC; Martins GR; Borin TF; Zuccari DA
Oncol Rep; 2015 May; 33(5):2345-53. PubMed ID: 25779537
[TBL] [Abstract][Full Text] [Related]
14. Positive correlation of steroid hormones and EGF in canine mammary cancer.
Queiroga FL; Pérez-Alenza D; Silvan G; Peña L; Illera JC
J Steroid Biochem Mol Biol; 2009 May; 115(1-2):9-13. PubMed ID: 19429455
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of mouse anti-canine PD-L1 monoclonal antibodies and their expression in canine tumors by immunohistochemistry
Sirivisoot S; Boonkrai C; Wongtangprasert T; Phakham T; Muanwein P; Pisitkun T; Sawangmake C; Radtanakatikanon A; Rungsipipat A
Vet Q; 2023 Dec; 43(1):1-9. PubMed ID: 37477617
[TBL] [Abstract][Full Text] [Related]
16. Next-generation RNA sequencing of FFPE subsections reveals highly conserved stromal reprogramming between canine and human mammary carcinoma.
Amini P; Nassiri S; Ettlin J; Malbon A; Markkanen E
Dis Model Mech; 2019 Aug; 12(8):. PubMed ID: 31308057
[TBL] [Abstract][Full Text] [Related]
17. Current biomarkers of canine mammary tumors.
Kaszak I; Ruszczak A; Kanafa S; Kacprzak K; Król M; Jurka P
Acta Vet Scand; 2018 Oct; 60(1):66. PubMed ID: 30373614
[TBL] [Abstract][Full Text] [Related]
18. Receptors for oestrogen, progesterone and epidermal growth factor in normal and tumorous canine mammary tissues.
Donnay I; Rauïs J; Wouters-Ballman P; Devleeschouwer N; Leclercq G; Verstegen JP
J Reprod Fertil Suppl; 1993; 47():501-12. PubMed ID: 8229969
[TBL] [Abstract][Full Text] [Related]
19. Correlation between Programmed Death Ligand-1(PD-L1) Expression and Driver Gene Mutations in Non-Small Cell Lung Carcinoma- Adenocarcinoma Phenotype.
Pandey RK; Shukla S; Husain N; Islam MH; Hadi R; Kant Tripathi S; Singhal A
Asian Pac J Cancer Prev; 2022 Jan; 23(1):131-142. PubMed ID: 35092381
[TBL] [Abstract][Full Text] [Related]
20. Expression of iNOS, COX-2 and VEGF in canine mammary tumours and non-neoplastic mammary glands: Association with clinicopathological features and tumour grade.
Anadol E; Yar Saglam AS; Gultiken N; Karakas K; Alcigir E; Alkan H; Kanca H
Acta Vet Hung; 2017 Sep; 65(3):382-393. PubMed ID: 28956485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]